OptimizeRx Corp
OPRX
View Detailed Chart
12.480USD
-0.280-2.19%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
232.03MMarket Cap
2888.89P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.19%
5 Days
-7.62%
1 Month
-18.27%
6 Months
-8.50%
Year to Date
+156.79%
1 Year
+145.19%
View Detailed Chart
TradingKey Stock Score of OptimizeRx Corp
Currency: USD Updated: 2025-12-26Key Insights
OptimizeRx Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 99/482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.33.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OptimizeRx Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Buy
Current Rating
24.333
Target Price
+73.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
OptimizeRx Corp Highlights
StrengthsRisks
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 47.52% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 92.13M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 92.13M.
Overvalued
The company’s latest PE is 2888.89, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 13.52M shares, decreasing 29.35% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 1.73K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.89.
OptimizeRx Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OptimizeRx Corp Info
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Ticker SymbolOPRX
CompanyOptimizeRx Corp
CEOSilvestro (Stephen L)
Websitehttps://www.optimizerx.com/
FAQs
What is the current price of OptimizeRx Corp (OPRX)?
The current price of OptimizeRx Corp (OPRX) is 12.480.
What is the symbol of OptimizeRx Corp?
The ticker symbol of OptimizeRx Corp is OPRX.
What is the 52-week high of OptimizeRx Corp?
The 52-week high of OptimizeRx Corp is 22.250.
What is the 52-week low of OptimizeRx Corp?
The 52-week low of OptimizeRx Corp is 3.991.
What is the market capitalization of OptimizeRx Corp?
The market capitalization of OptimizeRx Corp is 232.03M.
What is the net income of OptimizeRx Corp?
The net income of OptimizeRx Corp is -20.11M.
Is OptimizeRx Corp (OPRX) currently rated as Buy, Hold, or Sell?
According to analysts, OptimizeRx Corp (OPRX) has an overall rating of Buy, with a price target of 24.333.
What is the Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX)?
The Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX) is 0.004.
Related Instruments
-0.22%
-0.18%
-0.06%
-0.64%
+0.03%
+0.27%
+0.08%
-2.81%
+0.89%
+1.45%
+0.37%
+0.17%
+0.32%
-1.82%
+0.81%
+0.13%
+0.41%
+1.38%
+0.23%
+0.66%Popular Symbols
